Orchestra BioMed (OBIO) Insider Trading & Ownership $4.92 +0.12 (+2.50%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Orchestra BioMed (NASDAQ:OBIO) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.70%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$91,205.00Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$138,572.97 Get OBIO Insider Trade Alerts Want to know when executives and insiders are buying or selling Orchestra BioMed stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address OBIO Insider Buying and Selling by Quarter Ad Crypto 101 MediaThe #1 Coin for November 2024Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this newly established trust, I believe this coin could skyrocket up to 150x+ in the next 30 days alone! I've compiled everything you need to know about this once-in-a-lifetime DeFi project into a brand-new comprehensive guide… You can get access to the report by clicking here now… Orchestra BioMed Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/19/2024Andrew Lawrence TaylorCFOBuy1,000$4.83$4,830.00 12/18/2024David P HochmanInsiderBuy5,000$4.91$24,550.00 9/24/2024David P HochmanInsiderBuy2,500$4.91$12,275.00 9/9/2024Darren ShermanInsiderSell6,804$5.48$37,285.92 9/9/2024Eric S FainDirectorSell1,800$5.43$9,774.00 9/6/2024Darren ShermanInsiderSell6,819$5.65$38,527.35 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 9/6/2024Eric S FainDirectorSell2,000$5.64$11,280.00 9/4/2024Darren ShermanInsiderSell6,837$6.10$41,705.70 8/14/2024David P HochmanInsiderBuy2,500$5.84$14,600.00 6/25/2024David P HochmanInsiderBuy1,000$6.95$6,950.00 5/30/2024William Reed LittleInsiderBuy4,000$7.00$28,000.00 (Data available from 1/1/2013 forward) OBIO Insider Trading Activity - Frequently Asked Questions Who is on Orchestra BioMed's Insider Roster? The list of insiders at Orchestra BioMed includes Andrew Lawrence Taylor, Darren Sherman, David P Hochman, Eric S Fain, and William Reed Little. Learn more on insiders at OBIO. What percentage of Orchestra BioMed stock is owned by insiders? 6.70% of Orchestra BioMed stock is owned by insiders. Learn more on OBIO's insider holdings. Which Orchestra BioMed insiders have been buying company stock? The following insiders have purchased OBIO shares in the last 24 months: Andrew Lawrence Taylor ($4,830.00), David P Hochman ($58,375.00), and William Reed Little ($28,000.00). How much insider buying is happening at Orchestra BioMed? Insiders have purchased a total of 16,000 OBIO shares in the last 24 months for a total of $91,205.00 bought. Which Orchestra BioMed insiders have been selling company stock? The following insiders have sold OBIO shares in the last 24 months: Darren Sherman ($117,518.97), and Eric S Fain ($21,054.00). How much insider selling is happening at Orchestra BioMed? Insiders have sold a total of 24,260 Orchestra BioMed shares in the last 24 months for a total of $138,572.97 sold. Orchestra BioMed Key ExecutivesMr. David P. Hochman (Age 49)Founder, Chairman of the Board of Directors & CEO Compensation: $942k4 recent tradesMr. Darren R. Sherman (Age 53)Founder, President, COO & Director Compensation: $787k3 recent tradesMr. Andrew Lawrence Taylor M.B.A. (Age 53)Chief Financial Officer Compensation: $500.02k1 recent tradesMr. William Reed Little (Age 53)Executive Vice President of Corporate Development & Strategy Dr. Yuval Hay Mika D.Sc (Age 65)Ph.D., GM & CTO of Bioelectronic Therapies Dr. George Papandreou Ph.D. (Age 59)GM & Senior VP of Focal Therapies Dr. Hans-Peter Stoll M.D.Ph.D., Chief Clinical OfficerDr. Avraham Matityahu Fischer M.D. (Age 68)Senior Vice President of Medical Affairs & Innovation Mr. Bob LaughnerSenior Vice President of Regulatory & QualityMr. Juan LorenzoSenior Vice President of Product Development More Insider Trading Tools from MarketBeat Related Companies OFIX Insider Buying IRMD Insider Buying SIBN Insider Buying SRDX Insider Buying KIDS Insider Buying TMCI Insider Buying CLPT Insider Buying TCMD Insider Buying DCTH Insider Buying ANGO Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:OBIO) was last updated on 12/22/2024 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more t...Brownstone Research | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredBuffett's Oil Bet + This 22% Dividend PlayWarren Buffett has been quietly amassing a massive position in oil stocks. But while Buffett's picks (Occid...Investors Alley | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Orchestra BioMed Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Orchestra BioMed With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
